4890
Tsubota Laboratory Incorporated
坪田ラボ
- Industry
- Pharmaceutical
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Non-consolidated
Key metrics
Revenue(thousand JPY)
Mar 2022
640,921
Mar 2023
954,693
Mar 2024
673,532
Mar 2025
1,357,133
Mar 2026
200,022
Operating profit(thousand JPY)
Mar 2022
136,169
Mar 2023
167,031
Mar 2024
-649,554
Mar 2025
235,467
Mar 2026
-787,816
Operating profit margin(%)
Mar 2022
21.25
Mar 2023
17.5
Mar 2024
-96.44
Mar 2025
17.35
Mar 2026
-393.86
Profit before tax(thousand JPY)
Mar 2022
202,340
Mar 2023
144,221
Mar 2024
-636,371
Mar 2025
281,049
Mar 2026
-760,865
Profit(thousand JPY)
Mar 2022
153,319
Mar 2023
90,181
Mar 2024
-641,317
Mar 2025
205,766
Mar 2026
-761,815
Total assets(thousand JPY)
Mar 2022
1,617,795
Mar 2023
2,672,961
Mar 2024
2,295,159
Mar 2025
2,503,123
Mar 2026
1,318,780
Cash and cash equivalents(thousand JPY)
Mar 2022
1,174,929
Mar 2023
2,161,016
Mar 2024
1,883,400
Mar 2025
1,538,853
Mar 2026
969,849
Cash flows from operating activities(thousand JPY)
Mar 2022
654,914
Mar 2023
28,491
Mar 2024
-301,350
Mar 2025
-317,754
Mar 2026
-577,828
Cash flows from investing activities(thousand JPY)
Mar 2022
-72,228
Mar 2023
-54,027
Mar 2024
-12,001
Mar 2025
-14,547
Mar 2026
-8,409
Cash flows from financing activities(thousand JPY)
Mar 2022
-18,530
Mar 2023
1,011,623
Mar 2024
35,736
Mar 2025
-12,246
Mar 2026
17,234
Return on equity(%)
Mar 2022
22.96
Mar 2023
6.69
Mar 2024
-
Mar 2025
13.9
Mar 2026
-
Equity ratio(%)
Mar 2022
46.01
Mar 2023
72.97
Mar 2024
59.6
Mar 2025
63.4
Mar 2026
65.5
Earnings per share(JPY per share)
Mar 2022
6.77
Mar 2023
3.66
Mar 2024
-25.15
Mar 2025
8.04
Mar 2026
-29.58
Net assets per share(JPY per share)
Mar 2022
32.89
Mar 2023
77.07
Mar 2024
53.45
Mar 2025
61.91
Mar 2026
33.49
Dividend per share(-)
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-
Mar 2026
-
Payout ratio(-)
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-
Mar 2026
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.